Philips Research Press Release
|
April 7, 2008
Philips signs long-term healthcare research partnership with one of the largest Chinese hospitals
|
|
|
Shanghai, China – Royal Philips Electronics today announced that it
has signed a long-term research partnership agreement with the West
China Hospital, an affiliate of the Sichuan University in Chengdu,
China. Under the seven-year agreement, Philips will collaborate with
West China Hospital to develop new medical imaging procedures for
the diagnosis and monitoring of certain types of cardiovascular
disease (including coronary artery disease – one of the major
diseases in China), cancer and mental diseases.
Philips is consistently strengthening its position in the fast-growing Chinese healthcare market – a key element of the company's increased focus on emerging markets. “With 5,000 beds and two million outpatients, West China Hospital is one of the largest and most technologically advanced hospitals in China, and the perfect partner for Philips,” says Rick Harwig, CTO of Royal Philips Electronics. “I am convinced that the results of the joint research program will enable us to strengthen our support capabilities and to refine our products to meet the specific needs of medical facilities in China.” “At West China Hospital we strive to provide our patients with the best care they can receive in China, and advanced diagnosis is definitely critical to effective treatment and satisfactory medical services,” said Dr. Zong Guang Zhou, Vice Dean of West China Hospital, Sichuan University. “Being one of the largest medical facilities in China, West China Hospital hopes to leverage the industry-leading imaging capabilities of Philips through this research collaboration to accelerate the advancement of our imaging methodologies in areas such as cardiology, oncology and certain mental diseases.” Chronic diseases, including those caused by cardiovascular problems, cancer and diabetes, caused 80 per cent of deaths in China during the period 1991 to 2000. The lack of timely medical treatment and efficient prevention measures are the main reasons for the continuing high levels of such diseases. As a leading manufacturer of sophisticated medical equipment for diagnosis and treatment, Philips continually strives to enhance the efficacy of its medical technologies through research conducted with leading medical institutions. The Philips/West China Hospital collaboration will include eight new research projects involving medical imaging technologies such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). |
|
|
For more information please contact:Europe: Steve Klink China: Sherry Yu Philips Research Asia - Shanghai Tel: 021-2205-5979 Fax: 021-6354-4954 Email: sherry.lh.yu@philips.com Bella Ling Text 100 Tel: 021-64263989-226 Email: bella.ling@text100.com.cn |
|
About Royal Philips ElectronicsRoyal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a
global leader in healthcare, lighting and consumer lifestyle, delivering
people-centric, innovative products, services and solutions through the brand
promise of “sense and simplicity”. Headquartered in the Netherlands, Philips
employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27 billion in 2007, the company is a market leader in medical
diagnostic imaging and patient monitoring systems, energy efficient lighting
solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at
www.philips.com/newscenter.
|